IDO1 and acute respiratory distress syndrome: This is an indication that inflammatory signals during ARDS enhanced the IDO activity, which subsequently activated the kynurenine pathway, thereby participating in pathogenesis and disease progression, with a corresponding effect on clinical outcomes.